Pustulosis palmoplantaris is a disease distinct from psoriasis

References

• Hellgren L, Mobacken H. Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol. 1971;51(4):284–288.
   PubMed Web of Science ®Google Scholar
• Lomholt G. Prevalence of skin diseases in a population; A Census Study from the Faroe Islands. Dan Med Bull. 1964;11:1–7.
   PubMedGoogle Scholar
• Ashurst PJ. Relapsing pustular eruptions of the hands and feet. Br J Dermatol. 1964;76:169–180.
   PubMed Web of Science ®Google Scholar
• Enfors W, Molin L. Pustulosis palmaris et plantaris. A follow-up study of a ten-year material. Acta Derm Venereol. 1971;51(4):289–294.
   PubMed Web of Science ®Google Scholar
• Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006;212(4):327–337.
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Extra-palmoplantar lesions associated with palmoplantar pustulosis. J Eur Acad Dermatol Venerol. 2009;23:1227–1232.
   PubMed Web of Science ®Google Scholar
• Svejgaard A, Nielsen LS, Svejgaard E, Nielsen FK, Hjortshoj A, Zachariae H. HL-A in psoriasis vulgaris and in pustular psoriasis – Population and family studies. Br J Dermatol. 1974;91(2):145–153.
   PubMed Web of Science ®Google Scholar
• Henseler T, Christophers E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450–6.
   PubMed Web of Science ®Google Scholar
• Schilling F, Kessler S. Das SAPHO-Syndrom: Klinisch-rheumatologische und radiologische Differenzierung und Klassifizierung eines Krankengutes von 86 Fällen. Z Rheumatol. 2000;59:1–28.
   PubMed Web of Science ®Google Scholar
• Dumolard A, Gaudin P, Juvin R, Bost M, Peoch M, Phelip X. SAPHO syndrome or psoriatic arthritis? A familial case study. Rheumatology. 1999;38:463–467.
   PubMed Web of Science ®Google Scholar
• Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaelsson G, Evans J, Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120(4):627–632.
   PubMed Web of Science ®Google Scholar
• Eriksson MO, Hagforsen E, Lundin IP, Michaelsson G. Palmoplantar pustulosis: A clinical and immunohistological study. Br J Dermatol. 1998;138(3):390–398.
   PubMed Web of Science ®Google Scholar
• Michaelsson G, Gustafsson K, Hagforsen E. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol. 2006;54(4):737–738.
   PubMed Web of Science ®Google Scholar
• Ammoury A, El Sayed F, Dhaybi R, Bazex J. Palmoplantar pustulosis should not be considered as a variant of psoriasis. J Eur Acad Dermatol Venereol. 2008;22:363–404.
   PubMed Web of Science ®Google Scholar
• Favato G. High incidence of smoking habit in psoriatic patients. Am J Med. 2008;121(4):e17.
   Web of Science ®Google Scholar
• Naldi L. Cigarette smoking and psoriasis. Clin Dermatol. 1998;16(5):571–574.
   PubMed Web of Science ®Google Scholar
• Hagforsen E. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: Studies of the psoriasis variant palmoplantar pustulosis. Life Sci. 2007;80(24-25):2227–2234.
   PubMed Web of Science ®Google Scholar
• Mössner R, Kingo K, Kleensang A, Krüger U, Köning IR, Silm H, Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol. 2005;124:282–284.
   PubMed Web of Science ®Google Scholar
• Kuijpers AC, Zeeuwen PL, de Jongh GJ, van de Kerkhof PCM, Alkemande HA, Scheelwijk J. Skin derived antileukoproteinise (SKALP) is decreased in pustular forms of psoriasis. Arch Dermatol Res 1996;288:641–647.
   PubMed Web of Science ®Google Scholar
• Sakiyama H, Kobaqashi S, Dianzani U, Ogiuchi H, Kawashima M, Uchiyama T, Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci. 2008;50:197–207.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Bandoh N, Ueda S, Nozowa H, Goto T, Kishibe K, Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Immunol. 2009;157:71–82.
   PubMed Web of Science ®Google Scholar
• Marsland AM, Chalmers RJ, Hollis S, Leonardi-Bee J, Griffiths CE. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2006(1):CD001433.
   Google Scholar
• Adişen E, Tekin O, Gülekon A, Gürer MA. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol. 2009;23:814–819.
   PubMed Web of Science ®Google Scholar
• Egnatios G, Warthan MM, Pariser R, Hood AF. Pustular psoriasis following treatment of rheumatoid arthritis with TNF-alpha inhibitors. J Drugs Dermatol. 2008;7:975–977.
   PubMedGoogle Scholar
• Kuhara T, Watanabe D, Iwahori Y, Tamada Y, Yamamura M, Matsumoto Y. Psoriasiform and pustular eruption induced by etanercept and infliximab. Eur J Dermatol. 2009;19:388–389.
   PubMed Web of Science ®Google Scholar
• Rallis E, Korfitis C, Stavropoulou E, Papaconstantis M. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction? J Dermatolog Treat. 2009;1:1–3.
   Google Scholar
• Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: A class effect? J Rheumatol. 2007;34:434–437.
   PubMed Web of Science ®Google Scholar
• Mössner R, Thaci D, Mohr J, Pätzold S, Bertsch HP, Krüger U, Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: Report on five cases. Arch Dermatol Res. 2008; 300:101–105.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrouik J, Etanercept in the treatment of palmoplantar pustulosis. J Drugs Dermatol. 2008;7:940–946.
   PubMedGoogle Scholar
• Skov L, Beurskens FJ, Zachariae COC, Reitamo S, Teeling J, Satijn D, IL-8 as antibody therapeutic target in inflammatory diseases: Reduction of clinical activity in palmoplantar pustulosis. J Immunol. 2008;181:669–679.
   PubMed Web of Science ®Google Scholar